Wednesday, September 16, 2020

AstraZeneca’s US trial remains on hold pending FDA view

The British drugmaker and its partner, the University of Oxford, put research into the shot on hold last week after the volunteer suffered neurological symptoms

from mint - Companies https://ift.tt/3mqNJE9
https://ift.tt/eA8V8J

No comments:

Post a Comment